Coty (NYSE:COTY – Get Free Report) and Rejuvel Bio-Sciences (OTCMKTS:NUUU – Get Free Report) are both consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, profitability, analyst recommendations, valuation and risk.
Institutional & Insider Ownership
42.4% of Coty shares are owned by institutional investors. 6.0% of Coty shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Earnings and Valuation
This table compares Coty and Rejuvel Bio-Sciences”s gross revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Coty | $5.89 billion | 0.58 | $89.40 million | ($0.48) | -8.16 |
Rejuvel Bio-Sciences | N/A | N/A | N/A | N/A | N/A |
Coty has higher revenue and earnings than Rejuvel Bio-Sciences.
Volatility & Risk
Coty has a beta of 2, indicating that its share price is 100% more volatile than the S&P 500. Comparatively, Rejuvel Bio-Sciences has a beta of 0.39, indicating that its share price is 61% less volatile than the S&P 500.
Profitability
This table compares Coty and Rejuvel Bio-Sciences’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Coty | -6.24% | 5.18% | 1.70% |
Rejuvel Bio-Sciences | N/A | N/A | N/A |
Analyst Ratings
This is a summary of current recommendations for Coty and Rejuvel Bio-Sciences, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Coty | 2 | 13 | 4 | 0 | 2.11 |
Rejuvel Bio-Sciences | 0 | 0 | 0 | 0 | 0.00 |
Coty presently has a consensus target price of $6.3368, suggesting a potential upside of 61.86%. Given Coty’s stronger consensus rating and higher possible upside, research analysts plainly believe Coty is more favorable than Rejuvel Bio-Sciences.
Summary
Coty beats Rejuvel Bio-Sciences on 9 of the 10 factors compared between the two stocks.
About Coty
Coty Inc., together with its subsidiaries, manufactures, markets, distributes, and sells beauty products worldwide. It operates through Prestige and Consumer Beauty segments. The company provides fragrance, color cosmetics, and skin and body care products. It offers Prestige segment products primarily through prestige retailers, including perfumeries, department stores, e-retailers, direct-to-consumer websites, and duty-free shops under the Burberry, Calvin Klein, Chloe, Davidoff, Escada, Gucci, Hugo Boss, Jil Sander, Joop!, Kylie Jenner, Lancaster, Marc Jacobs, Miu Miu, Orveda, philosophy, SKKN BY KIM, and Tiffany & Co. brands. The company provides Consumer Beauty segment products primarily through hypermarkets, supermarkets, drug stores, pharmacies, mid-tier department stores, traditional food and drug retailers, and e-commerce retailers under the Adidas, Beckham, Biocolor, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, Max Factor, Mexx, Monange, Nautica, Paixao, Rimmel, Risque, and Sally Hansen brands. It also sells its products through third-party distributors. The company was founded in 1904 and is headquartered in New York, New York. Coty Inc. is a subsidiary of JAB Beauty B.V.
About Rejuvel Bio-Sciences
Rejuvel Bio-Sciences, Inc., a development stage company, produces, distributes, markets, and sells skin care products worldwide. The company primarily offers skin cream under the Rejuvel brand. It also intends to develop, build, and sell environmental management solutions that use electron particle accelerator technology for the treatment of drinking water, municipal and industrial wastewater, sludge, and produced water from oil and gas fracturing activities. The company was formerly known as Technology Applications International Corporation and changed its name to Rejuvel Bio-Sciences, Inc. in June 2015. Rejuvel Bio-Sciences, Inc. was founded in 2009 and is headquartered in Miami, Florida.
Receive News & Ratings for Coty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coty and related companies with MarketBeat.com's FREE daily email newsletter.